Tonix Pharmaceuticals (TNXP) News Today $0.24 +0.00 (+0.21%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by Analysts at StockNews.comJanuary 17 at 2:09 AM | americanbankingnews.comTonix appoints Gary Ainsworth as VP, market accessJanuary 9, 2025 | markets.businessinsider.comTonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market AccessJanuary 8, 2025 | finance.yahoo.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.2% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.2% - What's Next?January 7, 2025 | marketbeat.comTonix Pharmaceuticals to Present at Two Upcoming January Investor ConferencesJanuary 7, 2025 | finance.yahoo.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 2.5% Higher - Still a Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 2.5% - Here's WhyJanuary 6, 2025 | marketbeat.comSABBY MANAGEMENT, LLC Acquires 1,306,313 Shares in Tonix Pharmaceuticals Holding CorpJanuary 3, 2025 | gurufocus.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.5% - What's Next?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.5% - Should You Sell?January 3, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.5% - What's Next?Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 4.5% - What's Next?January 2, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.4% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 8.4% - Here's What HappenedJanuary 1, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Earns Hold Rating from Analysts at StockNews.comStockNews.com assumed coverage on shares of Tonix Pharmaceuticals in a research report on Wednesday. They set a "hold" rating for the company.January 1, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.8% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.8% - Here's WhyDecember 31, 2024 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 5.3% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 5.3% - Time to Sell?December 30, 2024 | marketbeat.comTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in DecemberTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 4,000,000 shares, a growth of 151.6% from the November 30th total of 1,590,000 shares. Based on an average daily volume of 93,440,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 2.1% of the shares of the stock are short sold.December 27, 2024 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.7% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 8.7% - Here's What HappenedDecember 27, 2024 | marketbeat.comTop 5 Biotech Stocks Dominating Retail Investor Conversations In 2024December 26, 2024 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.6% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.6% - Time to Sell?December 26, 2024 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.4% - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.4% - Here's WhyDecember 25, 2024 | marketbeat.comTonix Pharmaceuticals achieves key milestone with FDA review timeline for innovative Fibromyalgia treatmentDecember 24, 2024 | proactiveinvestors.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.2% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.2% - Should You Sell?December 24, 2024 | marketbeat.comTonix Pharma Awaits FDA Decision on TNX-102 SLDecember 23, 2024 | markets.businessinsider.comTonix announces PDUFA goal date for FDA decision on MA for TNX-102December 23, 2024 | markets.businessinsider.comTonix gets FDA target action date for TNX-102 SLDecember 23, 2024 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 26.8% - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 26.8% - Should You Sell?December 23, 2024 | marketbeat.comTonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for FibromyalgiaDecember 23, 2024 | globenewswire.comStockNews.com Begins Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)StockNews.com assumed coverage on Tonix Pharmaceuticals in a research report on Monday. They set a "hold" rating on the stock.December 23, 2024 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 11.3% - Time to Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.3% Higher - Should You Buy?December 20, 2024 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.7% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.7% - Should You Sell?December 19, 2024 | marketbeat.comTonix Pharmaceuticals Gets FDA Review of Fibromyalgia DrugDecember 18, 2024 | marketwatch.comTonix Pharma’s TNX-102 SL Nears FDA Approval MilestoneDecember 18, 2024 | markets.businessinsider.comFDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SLDecember 18, 2024 | msn.comWhat's Going On With Tonix Pharmaceuticals Stock Today?December 17, 2024 | benzinga.comTonix Pharmaceuticals announces FDA acceptance of NDA for TNX-102 SLDecember 17, 2024 | tipranks.comTonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for FibromyalgiaDecember 17, 2024 | globenewswire.comTonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational HighlightsDecember 16, 2024 | globenewswire.comHow Is The Market Feeling About Tonix Pharmaceuticals?December 12, 2024 | benzinga.comTonix Pharmaceuticals Holding Corp. Common Stock (TNXP) After-HoursDecember 11, 2024 | nasdaq.comTNXP: NDA Filed for TNX-102 SL in Fibromyalgia…December 4, 2024 | finance.yahoo.comTonix Pharma Expands Leadership Amid Drug DevelopmentDecember 4, 2024 | markets.businessinsider.comTonix Pharmaceuticals appoints Raudabaugh, Gould as VPsDecember 4, 2024 | markets.businessinsider.comTonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic HiresDecember 4, 2024 | finance.yahoo.comTonix Pharmaceuticals to Participate in the NobleCon20 Investor ConferenceNovember 26, 2024 | globenewswire.comMuscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and ApnimedNovember 21, 2024 | globenewswire.comTonix Pharmaceuticals presents data, analyses of TNX-102 SL effectsNovember 18, 2024 | markets.businessinsider.comTonix Pharmaceuticals to Present at the Winter 2024 Investor Summit VirtualNovember 18, 2024 | globenewswire.comTonix Pharma Reveals Promising TNX-801 Vaccine DataNovember 14, 2024 | markets.businessinsider.comTonix Pharmaceuticals announces publication of study on tolerability of TNX-801November 13, 2024 | markets.businessinsider.comTonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual MeetingNovember 13, 2024 | globenewswire.comTonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised AnimalsNovember 13, 2024 | globenewswire.comTonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational HighlightsNovember 12, 2024 | markets.businessinsider.com Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address TNXP Media Mentions By Week TNXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼-0.290.44▲Average Medical News Sentiment TNXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼13▲TNXP Articles Average Week Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADC Therapeutics News Genfit News Nkarta News Greenwich LifeSciences News Actuate Therapeutics News Vaxart News Lyell Immunopharma News Lexeo Therapeutics News Alector News Sutro Biopharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNXP Stock Alerts